Biomedical Engineering Reference
In-Depth Information
21. Szefl er SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ,
Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M,
Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA (2002) Signifi cant variability in
response to inhaled steroids for persistent asthma. J Allergy Clin Immunol 109(3):S410-S418
22. Everard ML, Dolovich MB (2002) In vivo measurements of lung dose. In: Bisgaard H,
O'Callaghan C, Smaldone GC (eds) Drug delivery to the lung. Dekker, New York, NY,
pp 173-209
23. Dolovich MB (1993) Lung dose, distribution, and clinical response to therapeutic aerosols.
Aerosol Sci Technol 18(3):230-240
24. American Thoracic Society (ATS) (1995) Standardization of spirometry—1994 update. Am J
Respir Crit Care Med 152(3):1107-1136
25. Tougas TP, Christopher D, Mitchell JP, Strickland H, Wyka B, Van Oort M, Lyapustina S
(2009) Improved quality control metrics for cascade impaction measurements of orally inhaled
drug products (OIPs). AAPS PharmSciTech 10(4):1276-1285
26. Mitchell JP, Nagel MW (2003) Cascade impactors for the size characterization of aerosols
from medical inhalers: their uses and limitations. J Aerosol Med 16(4):341-377
27. Olsson B, Borgstrom L, Asking L, Bondesson E (1996) Effect of inlet throat on the correlation
between measured fi ne particle dose and lung deposition. In: Dalby RN, Byron PR, Farr SJ
(eds) Respiratory drug delivery-V. Interpharm Press, Buffalo Grove, IL, pp 273-282
28. Ehtezazi T, Horsfi eld MA, Barry PW, O'Callaghan C (2004) Dynamic change of the upper
airway during inhalation via aerosol devices. J Aerosol Med 17(4):325-334
29. Ehtezazi T, Southern KW, Allanson D, Jenkinson I, O'Callaghan C (2005) Suitability of the
upper airway models obtained from MRI studies in simulating drug lung deposition from
inhalers. Pharm Res 22(1):166-170
30. Swift DL (1994) The oral airway—a conduit or collector for pharmaceutical aerosols. In:
Byron P, Dalby RN, Farr SJ (eds) Respiratory drug delivery IV. Interpharm Press, Buffalo
Grove, IL, pp 187-195
31. COPHIT
Consortium
(2012)
Anatomic
oropharyngeal
model,
at:
Visited 25 June 2012
32. McRobbie DW, Pritchard S, Quest RA (2003) Studies of the human oropharyngeal airspaces
using magnetic resonance imaging. I. Validation of a three-dimensional MRI method for pro-
ducing ex vivo virtual and physical casts of the oropharyngeal airways during inspiration.
J Aerosol Med 16(4):401-415
33. Ilie M, Matida EA, Finlay WH (2008) Asymmetrical aerosol deposition in an idealized mouth
with a DPI mouthpiece inlet. Aerosol Sci Technol 42(1):10-17
34. Zhang Y, Gilbertson K, Finlay WH (2007) In vivo-in vitro comparison of deposition in three
mouth-throat models with Qvar and Turbuhaler inhalers. J Aerosol Med 20(3):227-235
35. Stapleton KW, Guentsch E, Hoskinson MK, Finlay WH (2000) On the suitability of
k-turbulence modeling for aerosol deposition in the mouth and throat: a comparison with
experiment. J Aerosol Sci 31(6):731-749
36. Grgic B, Finlay WH, Heenan AF (2004) Regional aerosol deposition and fl ow measurements
in an idealized mouth and throat. J Aerosol Sci 35(1):21-32
37. Stocks J, Hislop AA (2002) Structure and function of the respiratory system. In: Bisgaard H,
O'Callaghan C, Smaldone GC (eds) Drug delivery to the lung. Dekker, New York, NY,
pp 47-104
38. Everard ML (2004) Inhaler devices in infants and children: challenges and solutions. J Aerosol
Med 17(2):186-195
39. Mitchell JP, Nagel MW, Doyle C, Ali RS, Avvakoumova V, Christopher D, Quiroz J, Strickland
H, Tougas T, Lyapustina S (2010) Relative precision of inhaler aerodynamic particle size dis-
tribution (APSD) metrics by full resolution and abbreviated Andersen Cascade Impactors
(ACIs): Part 1. AAPS PharmSciTech 11(2):843-851
40. Mitchell JP, Nagel MW, Doyle C, Ali RS, Avvakoumova V, Christopher D, Quiroz J, Strickland
H, Tougas T, Lyapustina S (2010) Relative precision of inhaler aerodynamic particle size
Search WWH ::
Custom Search